{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T23:28:34Z","timestamp":1653521314125},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.leukres.2011.06.007","type":"journal-article","created":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T18:37:26Z","timestamp":1312223846000},"page":"e179-e180","source":"Crossref","is-referenced-by-count":2,"title":["Response of concomitant chronic myelogenous leukemia and chronic lymphocytic leukemia to imatinib mesylate"],"prefix":"10.1016","volume":"35","author":[{"given":"Ju-Yoon","family":"Yoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajat","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Aloyz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2011.06.007_bib0005","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3109\/10428194.2011.555890","article-title":"The potential for dasatinib in treating chronic lymphocytic leukemia, acute myeloid leukemia, and myeloproliferative neoplasms","volume":"52","author":"Amrein","year":"2011","journal-title":"Leuk Lymph"},{"issue":"4","key":"10.1016\/j.leukres.2011.06.007_bib0010","first-page":"405","article-title":"Case report and literature review: a rare patient with chronic myeloid leukemia and chronic lymphocytic leukemia","volume":"38","author":"Bhagavathi","year":"2008","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.leukres.2011.06.007_bib0015","doi-asserted-by":"crossref","first-page":"7801","DOI":"10.1158\/0008-5472.CAN-05-3901","article-title":"c-Abl expression in chronic lymphocytic leukemia cells: clinical and therapeutic implications","volume":"66","author":"Lin","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2011.06.007_bib0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/sj.leu.2403247","article-title":"Imatinib sensitizes CLL lymphocytes to chlorambucil","volume":"18","author":"Aloyz","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2011.06.007_bib0025","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1182\/blood-2010-08-301176","article-title":"c-Abl regulates Mcl-1 gene expression in chronic lymphocytic leukemia cells","volume":"117","author":"Allen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.06.007_bib0030","doi-asserted-by":"crossref","DOI":"10.1007\/s00280-010-1530-7","article-title":"A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients","author":"Hebb","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"issue":"Dec 15 (13)","key":"10.1016\/j.leukres.2011.06.007_bib0035","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1182\/blood-2008-03-146704","article-title":"C-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches","volume":"112","author":"Hallaert","year":"2008","journal-title":"Blood"},{"issue":"Jan (1)","key":"10.1016\/j.leukres.2011.06.007_bib0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.leukres.2010.05.029","article-title":"p53 and autophagy contribute to dasatinib resistance in primary CLL lymphocytes","volume":"35","author":"Amrein","year":"2011","journal-title":"Leuk Res"},{"issue":"Oct 7 (14)","key":"10.1016\/j.leukres.2011.06.007_bib0045","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1182\/blood-2010-04-279786","article-title":"Dasatinib induces complete remission in a patient with primary cerebral involvement of B-cell chronic lymphocytic leukemia failing chemotherapy","volume":"116","author":"Russwurm","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2011.06.007_bib0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000318009","article-title":"Response to dasatinib in a patient with concomitant chronic myeloid leukemia and chronic lymphocytic leukemia","volume":"124","author":"Serpa","year":"2010","journal-title":"Acta Haematol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611002803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611002803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T21:30:19Z","timestamp":1543613419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212611002803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0145212611002803"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2011.06.007","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}